Popular Articles
-
Organizations in the News
(5 articles) University of Texas Health Science Center
(4 articles) University of Texas at Austin
(1 articles) UT Southwestern Medical Center
(1 articles) Cardiovascular Research Foundation
(1 articles) University of Florida
-
People in the News
-
St. Jude Medical Completes Acquisition of LightLab Imaging
Explore Article businesswire.com (Jul 6 2010)
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash. LightLab is the pioneer and leader in the development of Optical Coherence Tomography (OCT), a high resolution diagnostic coronary imaging technology which aids physicians in the treatment of cardiovascular disease. The acquisition of OCT technology accelerates the expansion of St. Jude Medical’s cardiovascular growth platform by providing the company with a comprehensive product offering that will allow the Company to compete in, and potentially expand, the intravascular imaging market. The IVUS ...
Comment on Article Mentions: LightLab Imaging David W. Kolstad Craig Kelley
-
Lantis Laser Signs Letter of Intent to Merge With Perio-Imaging Inc.
Explore Article GlobeNewswire, Inc. (Jun 16 2010)
Lantis Laser Inc. (OTCBB:LLSR) (http://www.lantislaser.com), announced today that it has signed a Letter of Intent to merge with Perio-Imaging Inc., a private New York based company. The merger would be an all stock transaction and closing, among other conditions, would be subject to raising the required funding to complete the proposed merged company's product development program. The name of the new merged company will be announced upon closing.
Comment on Article Mentions: LightLab Imaging Lawrence Livermore National Laboratory Massachusetts Institute of Technology
-
St. Jude Medical to Acquire LightLab Imaging for $90M in Cash
Explore Article Optical Coherence Tomography News (May 20 2010)
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, and LightLab Imaging, Inc. today announced a definitive agreement under which St. Jude Medical will acquire LightLab, a subsidiary of Goodman Co., Ltd. (JASDAQ: 7535) for approximately $90 million in cash. Acquisition of Optical Coherence Tomography technology provides St. Jude Medical with product platform to compete in and potentially expand $500 million coronary imaging market “We welcome LightLab and its employees to St. Jude Medical.” LightLab is the pioneer and leader in the development of Optical Coherence Tomography (OCT), a high resolution diagnostic coronary imaging technology which aids physicians in ...
Comment on Article Mentions: Lightlab C7 XR OCT Imaging System Lightlab C7 Dragonfly Imaging Catheter Daniel J. Starks
-
CardioSpectra founders win UT System Chancellor's award for entrepreneurship
Explore Article San Antonio Business Journal (Mar 17 2010)
University of Texas System Chancellor Francisco Cigarroa honored three professors within the system — including one in San Antonio — with the 2010 Chancellor’s Entrepreneurship and Innovation Award. Dr. Marc Feldman, associate professor of medicine and engineering at the University of Texas Health Science Center at San Antonio, was one of three professors within the UT System to receive the award. He and Tom Milner, the Marion E. Forsman Centennial Professor in Engineering at the University of Texas at Austin, were recognized for their development of a novel approach applied to cardiovascular imaging. They developed a technology to help cardiologists ...
Comment on Article Mentions: Marc D. Feldman University of Texas at Austin University of Texas Health Science Center
-
Lumen Biomedical sells core product to Volcano to generate much needed cash
Explore Article MedCity News (Feb 11 2010)
PLYMOUTH, Minnesota– Lumen Biomedical Inc. has sold one of its two clot removing devices to boost its balance sheet as the company struggles to stay afloat in a tough economy. Volcano Corporation, a San Diego-based medical device manufacturer, purchased Lumen’s Xtract catheter for an undisclosed sum. The company had been Xtract’s exclusive global distributor since May 2009. In an interview, Lumen CEO Steven Healy said the company wanted to move out of manufacturing and focus on product development. “We saw [the Volcano deal] as a way in a tough financial market to raise much needed funds,” Healy said. “Lots of ...Comment on Article Mentions: Volcano
-
Volcano Has AAA Week: Accused, Approved and Acquired
Explore Article ptca.org (Feb 10 2010)
Volcano Corporation (Nasdaq: VOLC) has had a pretty interesting week. Last Thursday was the low point: a 13 person jury in Massachusetts Superior Court found Volcano and its subsidiary Axsun liable for a number of contractual breaches against LightLab Imaging, Inc. These all grew out of Volcano's purchase of Axsun, a company that had exclusive contracts with LightLab, Volcano's main competitor in the Optical Coherence Tomography (OCT) field. The court has set March 22 as the start of the damages assessment phase. But today, Volcano made two more positive announcements. The FDA has approved Volcano's latest IVUS catheter, the Eagle ...
Comment on Article Mentions: LightLab Imaging Volcano Axsun Technologies
-
Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract Thrombus Aspiration Catheter
Explore Article Yahoo! Finance (Feb 9 2010)
SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical. Volcano became the exclusive global distributor of the Xtract™ catheter in May 2009. This acquisition reinforces Volcano's dedication to build a strategic portfolio of diagnostic and therapeutic tools to help patients with coronary artery disease at all levels of complexity, including acute myocardial infarction (AMI) or heart attacks.
Comment on Article Mentions: Volcano
-
Canon set to purchase Polish Optopol after lengthy talks
Explore Article Warsaw Business Journal (Dec 23 2009)
Japanese optical instrument producer Canon has agreed to spend a sum of zł.248 million to take over a 90 percent stake in publicly-listed Optopol Technology, a company which produces equipment for the ophthalmology sector. The two enterprises have managed to come to an agreement after almost a year of negotiations. The Bogdani family, the main shareholders in the domestic firm, will receive zł.19 for each share they sell, and they will sell almost 7.7 million shares while the remaining shareholders will sell shares at zł.20 per piece. Although Canon wanted to acquire a 100 percent stake in the firm, CEO ...Comment on Article Mentions: Optopol Technology Canon Medical Systems
-
Canon launches $94 million bid for Polish Optopol
Explore Article iii.co.uk (Dec 22 2009)
WARSAW, Dec 22 (Reuters) - Japanese company Canon has offered to buy Optopol, a Polish maker of equipment for eye surgery diagnostics, for 276 million zlotys ($94 million), a brokerage running the transaction said on Tuesday. The bid by the Japanese camera and office equipment maker values Optopol at 20 zlotys per share, although the Bogdani family has agreed to sell its 54 percent stake stake ...
Comment on Article Mentions: Optopol Technology Canon Medical Systems
-
Canon Bids $85M for Optopol, Polish Eye Diagnostic Device Maker
Explore Article Bloomberg.com (Dec 22 2009)
Dec. 22 (Bloomberg) -- Canon Inc. bid 248 million zloty ($85 million) to take over Optopol SA, a Polish maker of diagnostic equipment for eye doctors, as it seeks to take the lead in the sector. Canon offered to pay 19 zloty a share to members of the Bogdani family, and 20 zloty to other holders of the Zawiercie, Poland-based company’s stock, Canon said in a statement on its Web site. Optopol surged 22 percent to 19.62 zloty in Warsaw trading at 10:27 a.m. The benchmark WIG20 Index rose 1.2 percent. Canon is betting the acquisition will help reach its ...
Comment on Article Mentions: Optopol Technology Canon Medical Systems
-
Volcano Posts Q3 Loss; Backs FY09 View; Makes $11M milestone payment to Cardiospectra
Explore Article RTTNews (Nov 5 2009)
Volcano Corporation (VOLC: News ) reported a third-quarter GAAP net loss of $4.0 million or $0.08 per share, compared with a GAAP net income of $744 thousand or $0.01 per share in the year-ago quarter. Non-GAAP net income, which excludes stock-based compensation expense of $2.6 million and commissions of $1.4 million, was $7 thousand or $0.00 per share. This compares with the year-ago non-GAAP net income of $3.3 million or $0.06 per share, excluding stock-based compensation expense of $2.5 million. On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.12 per share. Analysts' ...Comment on Article Mentions: Volcano Axsun Technologies CardioSpectra
-
Opko Health’s New Acquisition (AMEX:OPK)
Explore Article istockanalyst.com (Oct 5 2009)
Formerly known as Ophthalmic Technologies Inc. Opko Health has recently agreed to acquire Chilean pharmaceutical company named Pharma Genexx for around US$ 16 million in cash. One of the reasons why this Florida-based pharma giant is taking up Chilean pharmaceutical is to enter the emerging markets in the future. The Miami-based Opko Health is a specialty healthcare company that is currently involved in the discovery, development and commercialization of pharmaceutical products, vaccines and diagnostic technologies. However, with this acquisition Opko Health is looking to expand into new areas like oncology and neurological disorders. Opko Health CEO and Chairman Philip Frost ...Comment on Article Mentions: OTI Ophthalmic Technologies Inc. UT Southwestern Medical Center
-
Optopol Reportedly Close To Being Acquired
Explore Article investing.businessweek.com (Sep 18 2009)
It was reported that Optopol Technology SA will be acquired by a trade investor. A source told "Parkiet" that the transaction would not take place this month, but once it has been signed, the sale process would accelerate. Adam Bogdani, the company's president, did not confirm or deny the information. It is expected Optopol will be acquired by Canon Inc.Comment on Article Mentions: Optopol Technology Canon Medical Systems
-
Thorlabs Acquires Covega
Explore Article Photonics.com (Mar 29 2009)
NEWTON, N.J., and FREMONT, Calif., March 24, 2009 – Photonics equipment maker Thorlabs Inc. has acquired Covega Corp., a provider of optoelectronic components and modules, for an undisclosed amount. The announcement was made jointly by Newton, N.J.-based Thorlabs and integrated photonics company Gemfire Corp. of Fremont, Calif., former owner of CovegaComment on Article Mentions: Thorlabs Alex E. Cable
-
Thorlabs acquires Covega from Gemfire
Explore Article semiconductor-today.com (Mar 26 2009)
Photonics component maker Thorlabs Inc of Newton, NJ has acquired optoelectronic component and subsystem maker Covega Corp of Jessup, MD from Gemfire Corp. Founded in 1999 as Codeon Corp before changing its name in 2003, Covega is a vertically integrated manufacturer of proprietary gain chips, semiconductor optical amplifiers (SOAs) and other indium phosphide (InP) based components and modules as well as lithium niobate (LiNbO3) technologyComment on Article Mentions: Thorlabs Alex E. Cable
RSS Feed
Recent Comments
Eric Swanson » Jim Fujimoto video: Biophotonics and optical coherence tomography
Great video Jim!
dariemihaela » Gary S. Mintz
Dear Prof. Dr. Gary S. Mintz, You are an extraordinary expert in imaging, an intelligence ...
See all recent comments